Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garraway, L. A.
Right arrow Articles by Sellers, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garraway, L. A.
Right arrow Articles by Sellers, W. R.
Related Collections
Right arrow Cellular Pathobiology
Right arrow Cellular Pathobiology: Cancer Genes and Genomics
[Cancer Research 66, 2506-2508, March 1, 2006]
© 2006 American Association for Cancer Research


Reviews

From Integrated Genomics to Tumor Lineage Dependency

Levi A. Garraway1,2,3,4 and William R. Sellers1,3,4

1 Department of Medical Oncology and 2 Melanoma Program in Medical Oncology, Dana-Farber Cancer Institute; 3 Department of Medicine, Brigham and Women's Hospital, Harvard Medical School; and 4 The Broad Institute of Harvard and MIT, Cambridge, Masachussetts

Requests for reprints: Levi A. Garraway, Department of Medical Oncology, Dana-Farber Cancer Institute, D1542, 44 Binney Street, Boston, MA 02115. Phone: 617-632-6689; Fax: 617-632-3460; E-mail: Levi_Garraway{at}dfci.harvard.edu.

In principle, genomic information derived from tumors should illuminate critical cellular dependencies that are tractable to therapeutic targeting; however, realizing this ideal remains difficult. Using an integrated analysis of high-resolution single nucleotide polymorphism maps and gene expression databases associated with the NCI60 collection cancer cell lines, we identified the transcription factor MITF as an amplified oncogene in melanoma that is critical for anchoring lineage dependence and malignant character. Similar combined genomic approaches may be useful in other cancer types to learn how critical regulators of tumor lineage are linked to genomic alterations in cancer cells. (Cancer Res 2006; 66(5): 2506-8)




This article has been cited by other articles:


Home page
Cancer Res.Home page
A. Gaur, D. A. Jewell, Y. Liang, D. Ridzon, J. H. Moore, C. Chen, V. R. Ambros, and M. A. Israel
Characterization of MicroRNA Expression Levels and Their Biological Correlates in Human Cancer Cell Lines
Cancer Res., March 15, 2007; 67(6): 2456 - 2468.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
W. Ruan, A. Sassoon, F. An, J. P. Simko, and B. Liu
Identification of Clinically Significant Tumor Antigens by Selecting Phage Antibody Library on Tumor Cells in Situ Using Laser Capture Microdissection
Mol. Cell. Proteomics, December 1, 2006; 5(12): 2364 - 2373.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
L. Chin, L. A. Garraway, and D. E. Fisher
Malignant melanoma: genetics and therapeutics in the genomic era.
Genes & Dev., August 15, 2006; 20(16): 2149 - 2182.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.